期刊文献+

临床路径在白内障临床医疗中的应用研究 被引量:6

Application of Clinical Pathway in Clinical Treatment of Cataract
下载PDF
导出
摘要 目的为提高医疗质量、规范诊疗过程、缩短住院天数、降低医疗费用、促进医疗资源的合理利用提供经验,对临床路径应用的实际效果进行分析,比较临床路径实施前后白内障临床治疗医疗质量的变化.方法采用历史回顾的方法,借助医院信息系统检索分别选择实施临床路径前和实施临床路径后的所有白内障相关入院患者的住院天数、术前住院日、住院总医疗费用、药费、检查费、患者满意率等进行统计分析.结果临床路径实施前后白内障病人的住院日、术前住院日、住院总费用、药费及检查费差异有统计学意义(P<0.05),均呈下降趋势.患者满意率较实行临床路径前有提升.结论在不削弱临床医疗效果的基础上,临床路径确实可以减少总住院费用、检查费及药费,规范诊疗流程,缩短住院日及术前住院日,并优化诊疗服务和提高服务质量. Objective To analyze effects of clinical pathway and compare medical qualities of clinical treatment of cataract before and after using clinical pathway.Method We used history review method to gather information of all inpatients with cataract before and after clinical pathway was used respectively with the aid of the hospital information system,and analyzed admission days,admission days before surgery,total hospitalization expenses,medicine fees,examination fees and patient satisfaction rates when the clinical pathway was used. Results After the clinical pathway was put into effect,there was statistical difference in admission days,admission days before surgery,total hospitalization expenses,medicine fees and examination fees of patients with cataract,and these indicators were all reduced. The satisfaction rates of patients were increased compared with those before using the clinical pathway.Conclusion The clinical pathway indeed lowers hospitalization expenses,medicine fees and examination fees while treatment effects are maintained,standardizes diagnosis and treatment process,shortens admission days and admission days before surgery,optimizes diagnosis and treatmentservices and improves service quality.
出处 《昆明医学院学报》 2010年第5期60-63,共4页 Journal of Kunming Medical College
关键词 临床路径 医院质量管理 白内障 Clinical pathway Hospital qualitymanagement Cataract
  • 相关文献

参考文献10

  • 1GREENFIELD E.Critical pathways:what they are and w-hat they are not[J].J Bum Care Rehabil,1995,16(2):196-197.
  • 2PEARSON S D,GOULART-FISHER D,LEE TH.Critical Pathways as a strategy for improving care; problems and potential[J].Ann Inten Med,1995,12 (3):941-948.
  • 3黄慧英.医疗质量保证的国际趋势[J].国外医学(医院管理分册),1999,16(1):1-5. 被引量:100
  • 4CRUMMER M B,CARTER V.Critical Pathway-the Pavotal too[J].Cardiovasc Vurs,1993,7(4):30-34.
  • 5鱼敏.关键路径法在美国医院中的应用[J].国外医学(医院管理分册),1996,13(2):61-63. 被引量:125
  • 6DARER J,PRONOVOST P,BASS E B.Use and evaluation of critical pathways in hospitals[J].Eff Clin Pract,2002,5(3):114-119.
  • 7HYETT K L,PODSKY M,SANTMARIA N,et al.Valuing variance:the importance of variance analysis in clinical pathways utilization[J].Aust Health Rev,2007,31 (4):565-570.
  • 8KIRSCHER S,WITZLEB W C,EBER LEIN-GONSKA M,et al.Clinical pathways.A useful steering instrument or a limitation for medical treatment[J].Orthopade,2007,36(6):516,518-522.
  • 9EITEL D R,RUDKIN S E,MALVEHY M A,et al.Improving service quality by understanding emergency department flow:a white paper and position statement prepared for the american academy of emergency medicine[J].J Emerg Med,2008,29(5):700-705.
  • 10LOPEZ-GASTON J I,SANCHEZ-MARIN B,MARTA J,et al.Application of a clinical pathway for the treatment of transient ischaemic attacks:implementation strategies and appraisal at two years[J].Rev Neural,2007,44 (12):715-719.

共引文献210

同被引文献25

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部